TC
Trium Capital Portfolio holdings
AUM
$163M
Turnover
55%
1-Year Est. Return
45.8%
This Fund
S&P 500
This Quarter
Est. Return
+19.63%
1 Year Est. Return
+45.8%
3 Year Est. Return
+188.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$289M
AUM Growth
+$16.9M
(+6.2%)
Cap. Flow
-$273K
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
46.33%
Holding
109
New
39
Increased
31
Reduced
16
Closed
21
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$10.9M |
| 2 |
APEN
Apollo Endosurgery, Inc.
APEN
|
+$9.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.48M |
| 4 |
NATI
National Instruments Corp
NATI
|
+$6.04M |
| 5 |
TA
TravelCenters of America LLC
TA
|
+$5.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SJI
South Jersey Industries, Inc.
SJI
|
+$9.66M |
| 2 |
ONEM
1Life Healthcare
ONEM
|
+$8.67M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$6.66M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$6.04M |
| 5 |
SWIR
Sierra Wireless
SWIR
|
+$5.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Miscellaneous | 20.73% |
| 3 | Technology | 13.76% |
| 4 | Industrials | 8.43% |
| 5 | Financials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $49.9M | 17.29% |
121,900
+21,700
| +22% | +$8.66M |
2022 Q4
1 quarter
|
|
|
OSH
2
DELISTED
Oak Street Health, Inc.
OSH
| $13.1M | 4.53% |
+338,197
| New | +$10.9M |
2023 Q1
0 quarters
|
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12M | 4.14% |
109,536
+85,776
| +361% | +$9.48M |
2022 Q4
1 quarter
|
|
|
SJR
4
DELISTED
Shaw Communications Inc.
SJR
| $11.1M | 3.85% |
371,873
+49,825
| +15% | +$1.44M |
2022 Q4
1 quarter
|
|
|
APEN
5
DELISTED
Apollo Endosurgery, Inc.
APEN
| $9.84M | 3.41% |
992,046
+959,558
| +2,954% | +$9.5M |
2022 Q4
1 quarter
|
|
6
Stryker
SYK
$108B
| $9.03M | 3.13% |
31,638
+845
| +3% | +$224K |
2022 Q4
1 quarter
|
|
7
Accenture
ACN
$132B
| $7.87M | 2.73% |
27,545
+778
| +3% | +$212K |
2022 Q4
1 quarter
|
|
8
Abbott
ABT
$178B
| $7.17M | 2.48% |
70,759
+8,234
| +13% | +$869K |
2022 Q4
1 quarter
|
|
9
Mastercard
MA
$528B
| $7M | 2.43% |
19,273
-55
| -0.3% | -$20K |
2022 Q4
1 quarter
|
|
|
TA
10
DELISTED
TravelCenters of America LLC
TA
| $6.72M | 2.33% |
+77,715
| New | +$5.11M |
2023 Q1
0 quarters
|
|
11
Otis Worldwide
OTIS
$26.3B
| $6.46M | 2.24% |
76,570
+2,209
| +3% | +$183K |
2022 Q4
1 quarter
|
|
12
Ecolab
ECL
$80.7B
| $6.39M | 2.21% |
38,589
-974
| -2% | -$152K |
2022 Q4
1 quarter
|
|
|
NATI
13
DELISTED
National Instruments Corp
NATI
| $6.32M | 2.19% |
+120,496
| New | +$6.04M |
2023 Q1
0 quarters
|
|
14
DELISTED
Ansys
ANSS
| $6.15M | 2.13% |
18,474
-4,306
| -19% | -$1.21M |
2022 Q4
1 quarter
|
|
15
Nike
NKE
$52.4B
| $5.99M | 2.08% |
48,843
-37
| -0.1% | -$4.55K |
2022 Q4
1 quarter
|
|
16
Alphabet (Google) Class A
GOOGL
$4.25T
| $5.74M | 1.99% |
55,284
-1,841
| -3% | -$177K |
2022 Q4
1 quarter
|
|
17
CME Group
CME
$103B
| $5.52M | 1.91% |
28,840
+761
| +3% | +$138K |
2022 Q4
1 quarter
|
|
|
MAXR
18
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $5.47M | 1.9% |
107,224
+81,571
| +318% | +$4.18M |
2022 Q4
1 quarter
|
|
19
Graco
GGG
$13B
| $5.33M | 1.85% |
72,951
+1,313
| +2% | +$91.2K |
2022 Q4
1 quarter
|
|
20
Moody's
MCO
$80.1B
| $5.27M | 1.83% |
17,224
+471
| +3% | +$142K |
2022 Q4
1 quarter
|
|
|
KBAL
21
DELISTED
Kimball International
KBAL
| $5.09M | 1.76% |
+410,346
| New | +$3.53M |
2023 Q1
0 quarters
|
|
22
UnitedHealth
UNH
$355B
| $4.86M | 1.68% |
10,276
+289
| +3% | +$139K |
2022 Q4
1 quarter
|
|
23
Adobe
ADBE
$93.7B
| $4.46M | 1.54% |
11,561
-4,212
| -27% | -$1.5M |
2022 Q4
1 quarter
|
|
24
VanEck Vietnam ETF
VNM
$458M
| $4.32M | 1.5% |
354,711
-5,600
| -2% | -$67.9K |
2022 Q4
1 quarter
|
|
|
DEN
25
DELISTED
Denbury Inc.
DEN
| $3.93M | 1.36% |
44,845
+486
| +1% | +$40.9K |
2022 Q4
1 quarter
|
|
Similar funds
VVM
GF
ACM
KFS
VB
RWA
CCM
CFG
Trium Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Trium Capital held 109 positions worth $289M, up 6.2% from $272M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Trium Capital's Q1 2023 filing shows 39 new, 31 increased, 16 reduced and 21 closed positions. Its largest new stake was Oak Street Health, Inc.: 338,197 shares worth $13.1M. The largest sale was South Jersey Industries, Inc., an estimated $9.66M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Miscellaneous and Technology.
- Trium Capital's largest Q1 2023 buy was Oak Street Health, Inc.: 338,197 shares worth $13.1M.
- Trium Capital added most to Apollo Endosurgery, Inc. in Q1 2023, an estimated $9.5M increase.
- Trium Capital's biggest Q1 2023 reduction was Golden Ocean Group, cutting an estimated $4.57M.
- Trium Capital fully exited South Jersey Industries, Inc. in Q1 2023, selling an estimated $9.66M.
- Trium Capital's ten largest holdings make up 46% of its $289M portfolio in Q1 2023.
- Trium Capital opened 39 new positions and closed 21 in Q1 2023.
- Trium Capital's portfolio value rose 6.2% quarter-over-quarter to $289M.
Based on Trium Capital's 13F filing for Q1 2023, filed 16 May 2023.